Skip to content
Disclosery

Medicxi Ventures Management (Jersey) Ltd

Follow

13F filer, CIK 1715579, ST. HELIER, Jersey

Medicxi Ventures Management (Jersey) Ltd reported $981,805,434 across 4 holdings for the quarter ended 2026-03-31, in a 13F-HR filed 2026-04-21.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001193125-26-166701

Period
2026-03-31
Reported value
$982M
Holdings
4
Top 10 weight
100%
New
0
Sold out
1

Largest buys vs the previous quarter

None.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
RAPT THERAPEUTICS INCexited-2,794,000-$94.6M
NAMSreduced-195,383-$6.25M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q1 2026

Share positions as resolved from 13F-HR 0001193125-26-166701, largest first. % of portfolio is the value over $981,805,434, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
CNTACENTESSA PHARMACEUTICALS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 19,963,157 shares; 2024Q4: 19,963,157 shares; 2025Q1: 19,963,157 shares; 2025Q2: 19,963,157 shares; 2025Q3: 19,963,157 shares; 2025Q4: 19,963,157 shares; 2026Q1: 19,963,157 shares 19,963,157$793M80.76%0Timeline
NAMSNEWAMSTERDAM PHARMA COMPANYQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 2,869,565 shares; 2024Q4: 2,869,565 shares; 2025Q1: 2,869,565 shares; 2025Q2: 2,869,565 shares; 2025Q3: 2,869,565 shares; 2025Q4: 2,869,565 shares; 2026Q1: 2,674,182 shares 2,674,182$85.6M8.72%-195,383Timeline
PHATPHATHOM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 7,464,572 shares; 2024Q4: 7,464,572 shares; 2025Q1: 7,464,572 shares; 2025Q2: 7,464,572 shares; 2025Q3: 7,464,572 shares; 2025Q4: 7,464,572 shares; 2026Q1: 7,464,572 shares 7,464,572$82.9M8.45%0Timeline
AURAAURA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 3,039,892 shares; 2024Q4: 3,039,892 shares; 2025Q1: 3,039,892 shares; 2025Q2: 3,039,892 shares; 2025Q3: 3,039,892 shares; 2025Q4: 3,039,892 shares; 2026Q1: 3,039,892 shares 3,039,892$20.3M2.07%0Timeline

Sold out in Q1 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
RAPT THERAPEUTICS INCRAPT THERAPEUTICS INC2,794,000$94.6Mshares

How Q1 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001193125-26-166701 base2026-04-21acceptance time not in the bulk data set